Investigation of Incidence of influenza symptom and adverse reaction by subcutaneous or intramuscular injection in influenza vaccine.

Investigation of Incidence of influenza symptom and adverse reaction by subcutaneous or intramuscular injection in influenza vaccine. - Investigation of Incidence of influenza symptom and adverse reaction by subcutaneous or intramuscular injection in influenza vaccine.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034112

Enrollment

3000

Registered

2018-10-01

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hospital staff and university students who received influenza vaccine.

Exclusion criteria

Exclusion criteria: Influenza vaccine contraindicated. No acceptance of research consent.

Design outcomes

Primary

Measure	Time frame
Incidence of influenza symptom(influenza-like illnesses)	—

Secondary

Measure	Time frame
Incidence rate of local adverse reactions that interfere with daily life. degree of local adverse reaction. Pain at the time of injection. Feeling resistance to receiving next vaccination. Serious adverse reaction.	—

Countries

Japan

Contacts

Public ContactKenichiro MAJIMA

Kameda Medical Center Department of Health Management,

majima.kenichiro@kameda.jp04-7092-2211

Outcome results